Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2

被引:0
|
作者
Rosanna Cardani
Marzia Giagnacovo
Annalisa Botta
Fabrizio Rinaldi
Alessandra Morgante
Bjarne Udd
Olayinka Raheem
Sini Penttilä
Tiina Suominen
Laura V. Renna
Valeria Sansone
Enrico Bugiardini
Giuseppe Novelli
Giovanni Meola
机构
[1] IRCCS Policlinico San Donato,Lab of Muscle Histopathology and Molecular Biology
[2] University of Milan,CMN
[3] University of Pavia,Neuromuscular Disease Center, IRCCS Policlinico San Donato
[4] Tor Vergata University of Rome,Department of Animal Biology
[5] University of Tampere,Department of Biopathology and Diagnosing Imaging
[6] University of Helsinki,Neuromuscular Research Unit
[7] University of Helsinki,Department of Medical Genetics, Haartman Institute
[8] Tampere University Hospital,Department of Medical Genetics, Folkhälsan Institute of Genetics
[9] Vaasa Central Hospital,Department of Neurology
[10] University of Milan,Department of Neurology
[11] San Peter Hospital,Department of Neurology, IRCCS Policlinico San Donato
[12] National Agency for the Evaluation of Universities and Research,undefined
[13] ANVUR,undefined
来源
Journal of Neurology | 2012年 / 259卷
关键词
Myotonic dystrophy type 2; Juvenile case; Muscle pathology; Myotonia congenita;
D O I
暂无
中图分类号
学科分类号
摘要
Myotonic dystrophy type 2 (DM2) is a common adult onset muscular dystrophy caused by a dominantly transmitted (CCTG)n expansion in intron 1 of the CNBP gene. In DM2 there is no obvious evidence for an intergenerational increase of expansion size, and no congenital cases have been confirmed. We describe the clinical and histopathological features, and provide the genetic and molecular explanation for juvenile onset of myotonia in a 14-year-old female with DM2 and her affected mother presenting with a more severe phenotype despite a later onset of symptoms. Histological and immunohistochemical findings correlated with disease severity or age at onset in both patients. Southern blot on both muscle and blood samples revealed only a small increase in the CCTG repeat number through maternal transmission. Fluorescence in situ hybridization, in combination with MBNL1 immunofluorescence on muscle sections, showed the presence of mutant mRNA and MBNL1 in nuclear foci; the fluorescence intensity and its area appeared to be similar in the two patients. Splicing analysis of the INSR, CLCN1 and MBNL1 genes in muscle tissue demonstrates that the level of aberrant splicing isoforms was lower in the daughter than in the mother. However, in the CLCN1 gene, a heterozygous mutation c.501C>G p.F167L was present in the daughter’s DNA and found to be maternally inherited. Biomolecular findings did not explain the unusual young onset in the daughter. The co-segregation of DM2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings.
引用
收藏
页码:2090 / 2099
页数:9
相关论文
共 50 条
  • [21] Progressive frontal lobe impairment in myotonic dystrophy type 1 (DM1) and type 2 (DM2): A longitudinal study
    Meola, G
    Sansone, V
    Gandossini, S
    Milanese, SD
    Cattaneo, E
    Brescia, A
    Cotticelli, B
    Zanetti, O
    Calabria, M
    Cotelli, M
    Binetti, G
    NEUROLOGY, 2005, 64 (06) : A415 - A415
  • [22] Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM)
    Flachenecker, P
    Schneider, C
    Cursiefen, S
    Ricker, K
    Toyka, KV
    Reiners, K
    NEUROMUSCULAR DISORDERS, 2003, 13 (04) : 289 - 293
  • [23] Abnormal splicing of SERCA1 and RYR1 in myotonic dystrophy type 2 (DM2)
    Vihola, Anna
    Raheem, Olayinka
    Haapasalo, Hannu
    Suominen, Tiina
    Holmlund-Hampf, Jeanette
    Paetau, Anders
    Cardani, Rosanna
    Meola, Giovanni
    Kalimo, Hannu
    Krahe, Ralf
    Udd, Bjarne
    NEUROMUSCULAR DISORDERS, 2006, 16 : S153 - S154
  • [24] High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany
    T. Suominen
    B. Schoser
    O. Raheem
    S. Auvinen
    M. Walter
    R. Krahe
    H. Lochmüller
    W. Kress
    B. Udd
    Journal of Neurology, 2008, 255
  • [25] High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany
    Suominen, Tiina
    Schoser, Benedikt
    Raheem, Olayinka
    Auvinen, Satu
    Walter, Maggie
    Krahe, Ralf
    Lochmueller, Hanns
    Kress, Wolfram
    Udd, Bjarne
    JOURNAL OF NEUROLOGY, 2008, 255 (11) : 1731 - 1736
  • [26] Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings
    Pisani, V.
    Botta, A.
    Bonifazi, E.
    Panico, M.
    Marfia, G.
    Bernardi, G.
    Novelli, G.
    Massa, R.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 857 - 857
  • [27] The parkinsonism-myotonic-myopathy-complex: Development of parkinsonism in a patient with myotonic dystrophy type 2 (DM2)
    Lolekha, P.
    Agarwal, P. A.
    McKeown, M. J.
    MOVEMENT DISORDERS, 2011, 26 : S341 - S341
  • [28] Increased K+ release during exercise in myotonic dystrophy type 1 (DMl) but not type 2 (DM2, PROMM)
    Hanisch, F.
    Eger, K.
    Hart, H.
    Scharf, A.
    Kornhuber, M.
    Zierz, S.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 671 - 671
  • [29] Systematic survey of EMG and neurographic findings in myotonic dystrophy Types 1 (DM1) and 2 (DM2)
    Khizanishvili, N.
    Stahl, K.
    Montagnese, F.
    Wenninger, S.
    Antia, A.
    Kvirkvelia, N.
    Schoser, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 689 - 689
  • [30] Sub-Regional Body Composition and Clinical Endpoints in Myotonic Dystrophy Type 2 (DM2)
    Puwanant, Araya
    Isfort, Michael C.
    Kelleher, Annmarie
    Brown, Kathryn
    Su, Xiaowei William
    Clemens, Paula R.
    ANNALS OF NEUROLOGY, 2018, 84 : S116 - S116